Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice

• मुख्य लेखकों: Allan K. N. Alencar (लेखक), Pedro M. Pimentel-Coelho (लेखक), Guilherme C. Montes (लेखक), Marina de M. C. da Silva (लेखक), Luiza V. P. Mendes (लेखक), Tadeu L. Montagnoli (लेखक), Ananssa M. S. Silva (लेखक), Juliana Ferreira Vasques (लेखक), Paulo Henrique Rosado- (लेखक), Bianca Gutfilen (लेखक), Valéria do M. N. Cunha (लेखक), Aline G. M. Fraga (लेखक), Patrícia M R e Silva (लेखक), Marco Aurélio Martins (लेखक), Tatiana Paula Teixeira Ferreira (लेखक), Rosalia Mendes-Otero (लेखक), Margarete M. Trachez (लेखक), Roberto T. Sudo (लेखक), Gisele Zapata-Sudo (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Aims: Pulmonary arterial hypertension (PAH) is a disease characterized by an increase in pulmonary vascular resistance and right ventricular (RV) failure. We aimed to determine the effects of human mesenchymal stem cell (hMSC) therapy in a SU5416/hypoxia (SuH) mice model of PAH.Methods and Results:...